Clinical Trials Directory

Trials / Unknown

UnknownNCT04561154

Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV

Identifying Functional and Psycho-social Complaints After Hospitalization for Severe SARS-CoV-2 Infection (COVID19)- REPERCOV

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
134 (estimated)
Sponsor
Centre Hospitalier le Mans · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Since December 2019, China and then the rest of the world have been affected by the rapid spread of a new coronavirus infection called SARS-CoV-2 (severe acute respiratory syndrome coronavirus), the clinical expression of which is called Covid-19 (Coronavirus Disease 2019). It is estimated that around 20% of symptomatic patients will be severe enough to warrant hospitalization, of which around 5% will be in intensive care. Organ damage is multiple in Covid infection: respiratory, digestive, renal, neurological, cardiovascular due to the infection or its care. There is also a psychological and social impact of the infection or of the care that should be measured. In this context, investigator will assess the physical and psychological complaints of patients who have presented a severe form of SARS-CoV-2 infection. The final objective being to identify the needs to offer follow-up adapted to this emerging pathology.

Conditions

Interventions

TypeNameDescription
OTHERquestionnairethree months after hospitalization, a questionnaire will be sent to patients. If necessary, patient will be seen in consultation of geriatry, otorhinolaryngology, pneumology, neuropsychology

Timeline

Start date
2020-06-11
Primary completion
2021-06-11
Completion
2022-06-11
First posted
2020-09-23
Last updated
2022-03-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04561154. Inclusion in this directory is not an endorsement.